EU investigates Sanofi flu vaccine antitrust
The investigation examines how the company marketed Efluelda, an enhanced flu vaccine intended for people over 60, focusing on its promotion and claims of greater protection.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading